GCM
GILD icon

Goldstream Capital Management’s Gilead Sciences GILD Stock Holding History

Goldstream Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,246
Closed -$153K – 40
2025
Q4 		$153K Hold
1,246
– – 0.06% 52
2025
Q3 		$138K Hold
1,246
– – 0.03% 49
2025
Q2 		$138K Hold
1,246
– – 0.05% 50
2025
Q1 		$140K Hold
1,246
– – 0.06% 43
2024
Q4 		$115K Hold
1,246
– – 0.03% 43
2024
Q3 		$104K Buy
+1,246
New +$95.1K 0.04% 51
2023
Q4 		– Sell
-1,253
Closed -$93.9K – 40
2023
Q3 		$93.9K Hold
1,253
– – 0.07% 48
2023
Q2 		$96.6K Buy
1,253
+459
+58% +$36.6K 0.07% 43
2023
Q1 		$65.9K Buy
+794
New +$65.8K 0.07% 41

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Goldstream Capital Management's GILD Position: Q1 2026 in Review

Goldstream Capital Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 1,246 shares — an estimated $153K sold.

Goldstream Capital Management first reported a position in GILD in Q1 2023 and held it in 9 quarters. The position peaked at $153K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Goldstream Capital Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Goldstream Capital Management sold 1,246 Gilead Sciences shares in Q1 2026, an estimated $153K.
  • Goldstream Capital Management first reported a position in Gilead Sciences in Q1 2023 and held it in 9 quarters.
  • Goldstream Capital Management's Gilead Sciences position peaked at $153K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Goldstream Capital Management's 13F filing for Q1 2026, filed 15 May 2026.